EUCTR2016-004012-35-AT进行中（未招募）1 期
Effect of albumin infusion on oxidative albumin modification, albumin binding capacity and plasma thiol status
Medical University of Graz0 个研究点开始时间: 2016年12月14日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Routine indication for albumin infusion (hepatorenal syndrome, spontaneous bacterial peritonitis, large-volume paracentesis)
- •- Age >18 years
- •- Informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •- Malignant ascites
- •- Presence of hepatocellular carcinoma or advanced extrahepatic neoplasia
- •- Nephrotic syndrome
- •- Albumin infusion >80g within the last 48 hours
- •- Pregnancy
研究者
相似试验
已完成
不适用
Effect of Albumin Infusion on Oxidative Albumin Modification, Albumin Binding Capacity and Plasma Thiol StatusDecompensated CirrhosisNCT03214796Medical University of Graz40
尚未招募
2 期
A study of impact of low dose albumin infusion on outcome in patients with cirrhosis and sepsisCTRI/2020/03/023794Kalinga Institute Of Medical Sciences
尚未招募
不适用
Therapeutic measures in Sepsis patients.CTRI/2020/07/026429Maulana Azad Medical College
已完成
3 期
Albumin protein and malnutrition indices in primary school childreIRCT20210109049971N1Shiraz University of Medical Sciences60
招募中
3 期
The effect of injectable albumin on renal and coagulation system activityCondition 1: Chronic kidney disease. Condition 2: Coagulapathy.Chronic kidney disease (CKD)Coagulation defect, unspecifiedD68.9IRCT20191009045037N1Shahre-kord University of Medical Sciences80